Skip to content

Immunomodulatory action of Balchaturbhadra Syrup in Lowering Down Morbidity in children

Clinical Study to Evaluate the Immunomodulatory Effect of Balchaturbhadra Syrup in lowering down Morbidity of Children

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045142
Enrollment
50
Registered
2022-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

University Post Graduate Institute of Ayurved Studies and Research DSRRAU Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Children age group from 1 Year to 05 years. 2.Children having recurrent URTI. 3.Children having recurrent GIT Disease. 4.Children having other recurrent disease.

Exclusion criteria

Exclusion criteria: 1.Children age below 1 year & above 05 years of age. 2.Children having history of hypersensitivity to trial drug or their ingredient. 3.Children who have completed participation in any trial drug past 6 months. 4.Children those having chronic respiratory illness like tuberculosis, pleural effusion, bronchiectasis, lung carcinoma, COPD and Chronic lung disease will be excluded. 5.Children those having chronic GIT disorders like abdominal tuberculosis, chronic ailments and any tumors will be excluded. 6.Children having Diabetes Mellitus, any malignant conditions, genetic disorders and congenital disorders will be excluded.

Design outcomes

Primary

MeasureTime frame
To see the effect of Balchaturbhadra Syrup in lowering down the morbidity in children.Timepoint: 45 days

Secondary

MeasureTime frame
To observe demographical status of morbidity in children in defined population.Timepoint: 45 Days

Countries

India

Contacts

Public ContactDr MOHIT SHARMA

University Post Graduate Institute of Ayurveda Studies and Research DSRRAU Jodhpur

drharish_md@yahoo.co.in9636622206

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026